Rat × rat hybrid myelomas and a monoclonal anti-Fd portion of mouse IgG View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1979-01

AUTHORS

B. WRIGHT, C. MILSTEIN, G. GALFRÈ

ABSTRACT

MONOCLONAL antibodies can be produced by cultures of permanent cell lines derived by fusion of suitable myelomas with spleen cells from immunised animals1. So far, mainly two mouse myelomas, X63-Ag8 and NSI/1-Ag4.1, have been used for this purpose1,2. When cells from immunised mice are used in the fusion, the mouse × mouse hybrid myelomas can be grown as tumours in appropriate mouse strains. We describe here the preparation and use of a new clone of a rat myeloma, which is suitable for the derivation of rat × rat hybrid myelomas producing specific rat antibodies. The spent medium of hybrid myeloma cultures usually contains 1–20 μg ml−1 antibody. The serum and ascites of the tumour-bearing mice, with few exceptions, yield 1–20 mg ml−1 of antibody, which is 1,000 times more concentrated and very convenient for larger preparations. More... »

PAGES

131

Journal

TITLE

Nature

ISSUE

5692

VOLUME

277

Related Patents

  • Ligand Having Agonistic Activity To Mutated Receptor
  • Agents For Ameliorating Low Vasopressin Level
  • Lipoprotein Lipase Suppression By Endotoxin-Induced Mediator (Shock Assay)
  • Pharmaceutical Compositions Containing Sc(Fv)2
  • Anti P2x7 Receptor Antibodies And Fragments Thereof
  • P2x7 Epitopes
  • Monoclonal Antibody Inducing Apoptosis
  • Combination Therapy
  • Degraded Tpo Agonist Antibody
  • Improvements In Or Relating To Cell Lines
  • Therapeutic Agent For Hematopoietic Tumors
  • Non-Functional P2x7 Receptor
  • Antibodies To Non-Functional Oligomeric P2x7 Receptors And Methods Of Use Thereof
  • Companion Animal Treatments
  • Structural Isomers Of Sc(Fv)2
  • Anti-Mpl Antibodies
  • Method For Reducing Adverse Effects Of A Human 70kda Mediator Which Results From Endotoxin Stimulation Of Macrophages
  • Antibodies To Non-Functional P2x7 Receptor
  • Therapeutic Agent For Cachexia
  • Antibodies For Binding To Non-Functional P2x7 Receptors In Trimeric Form
  • Anti P2x7 Receptor Antibodies And Fragments Thereof
  • Peptides For Inducing Antibodies To A Non-Functional P2x7 Receptor
  • Peptides For Generating An Antibody Selectively Binding To A Non-Atp-Binding P2x7 Receptor But Not To An Atp-Binding P2x7 Receptor
  • Hybridomas Producing Antibodies Against Non Functional P2x7 Receptor
  • Monoclonal Anti-Human Igg Antibody And Process For Preparing The Same
  • Methods Of Treating Cancer With Antibodies That Bind P2x7 Receptors
  • Methods Of Improving Vaccine Immunogenicity
  • Polypeptide Inducing Apoptosis
  • Methods For Inhibiting Cell Proliferation
  • Degraded Tpo Agonist Antibody
  • Improvements In Or Relating To Cell Lines
  • Anti P2x7 Receptor Antibodies And Fragments Thereof
  • Detection Of Complexes Which Include Basement Membrane Components As Diagnostic Of Cancer And Other Diseases
  • Detection Of Complexes Which Include Basement Membrane Components As Diagnostic Of Cancer And Other Diseases
  • Therapeutic Agent For Hematopoietic Tumors
  • Pharmaceutical Compositions Containing Sc(Fv)2
  • Purinergic (P2x) Receptors In Extra-Cellular Body Fluid
  • Anti-Mpl Antibodies
  • Monoclonal Anti-Human Igg Antibody And Process For Preparing The Same
  • Antibody Against Human Parathormone Related Peptides
  • Methods And Compositions For Increasing Protein Yield From A Cell Culture
  • Improvements In Or Relating To Cell Lines
  • Therapeutic Composition For Treatment Of Glioblastoma
  • Non-Functional P2x7 Receptor
  • Antibodies Against Human Parathyroid Hormone Related Protein
  • Cell Death-Inducing Agent
  • Method For Treating Myeloma Utilizing An Expression Enhancer For Hm1.24 Antigen
  • Antibodies To Non-Functional P2x7 Receptor
  • Antibodies Against Human Parathyroid Hormone Related Protein
  • Stabilizer For Protein Preparation Comprising Meglumine And Use Thereof
  • Antigen Binding Sites To Non-Functional Oligomeric P2x7 Receptors And Methods Of Use Thereof
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/277131a0

    DOI

    http://dx.doi.org/10.1038/277131a0

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1039142189

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/310519


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Immunology", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antibodies, Anti-Idiotypic", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antibody Specificity", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cell Line", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Clone Cells", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Hybrid Cells", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Immunoglobulin Fragments", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Immunoglobulin G", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Myeloma Proteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Neoplasms, Experimental", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Plasmacytoma", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Rats", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Species Specificity", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "familyName": "WRIGHT", 
            "givenName": "B.", 
            "id": "sg:person.01305136127.21", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01305136127.21"
            ], 
            "type": "Person"
          }, 
          {
            "familyName": "MILSTEIN", 
            "givenName": "C.", 
            "id": "sg:person.0104563066.64", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0104563066.64"
            ], 
            "type": "Person"
          }, 
          {
            "familyName": "GALFR\u00c8", 
            "givenName": "G.", 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/256495a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001387921", 
              "https://doi.org/10.1038/256495a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/244042a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1004074762", 
              "https://doi.org/10.1038/244042a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1073/pnas.71.9.3440", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1014786242"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/266550a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1023163215", 
              "https://doi.org/10.1038/266550a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/eji.1830080802", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1026826519"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1111/j.1600-065x.1977.tb00382.x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1027700902"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1111/j.1432-1033.1975.tb02478.x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1037964148"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/ijc.2910100316", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1039713270"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1042/bj1160249", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1041484764"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1042/bj1160249", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1041484764"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1073/pnas.63.1.78", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1047016203"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1042/bj1280427", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1050611617"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1042/bj1280427", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1050611617"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1021/bi00777a002", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1055188173"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "1979-01", 
        "datePublishedReg": "1979-01-01", 
        "description": "MONOCLONAL antibodies can be produced by cultures of permanent cell lines derived by fusion of suitable myelomas with spleen cells from immunised animals1. So far, mainly two mouse myelomas, X63-Ag8 and NSI/1-Ag4.1, have been used for this purpose1,2. When cells from immunised mice are used in the fusion, the mouse \u00d7 mouse hybrid myelomas can be grown as tumours in appropriate mouse strains. We describe here the preparation and use of a new clone of a rat myeloma, which is suitable for the derivation of rat \u00d7 rat hybrid myelomas producing specific rat antibodies. The spent medium of hybrid myeloma cultures usually contains 1\u201320 \u03bcg ml\u22121 antibody. The serum and ascites of the tumour-bearing mice, with few exceptions, yield 1\u201320 mg ml\u22121 of antibody, which is 1,000 times more concentrated and very convenient for larger preparations.", 
        "genre": "research_article", 
        "id": "sg:pub.10.1038/277131a0", 
        "inLanguage": [
          "en"
        ], 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1018957", 
            "issn": [
              "0090-0028", 
              "1476-4687"
            ], 
            "name": "Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "5692", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "277"
          }
        ], 
        "name": "Rat \u00d7 rat hybrid myelomas and a monoclonal anti-Fd portion of mouse IgG", 
        "pagination": "131", 
        "productId": [
          {
            "name": "readcube_id", 
            "type": "PropertyValue", 
            "value": [
              "ba73d542b2591b6bcfff0b8484c801331fa48fe244c78ae58965035ef4975b7c"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "310519"
            ]
          }, 
          {
            "name": "nlm_unique_id", 
            "type": "PropertyValue", 
            "value": [
              "0410462"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/277131a0"
            ]
          }, 
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1039142189"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/277131a0", 
          "https://app.dimensions.ai/details/publication/pub.1039142189"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2019-04-10T15:38", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8664_00000425.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://www.nature.com/articles/277131a0"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/277131a0'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/277131a0'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/277131a0'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/277131a0'


     

    This table displays all metadata directly associated to this object as RDF triples.

    167 TRIPLES      21 PREDICATES      54 URIs      34 LITERALS      22 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/277131a0 schema:about N00b895534e3b412d97fbdc7dbbeb13a2
    2 N30181fc9028743d38f96929f32a59e7b
    3 N3118181ff9104491b3f311320bbe230e
    4 N3dad8b9f849f4ee0b3de04354ad2e533
    5 N4d6f4a6e14b54d9093ee02e831dbae40
    6 N6c1a61993b204480b3f5ed2707e29989
    7 N7b5147d79f254c039d9c429ff8feab5f
    8 N896656efa8f34d6597e10521aaa7d5fc
    9 N915452b8c7ac414eacbe25adecc2e9a1
    10 Na5c4864df17249538080e05d275338c6
    11 Nb16754d4764142aa970734c9bb9387bb
    12 Nc51cc365c1094967bf06b6f055c6ab16
    13 Nd9a53f33818c49168fd18a1341f0ab54
    14 anzsrc-for:11
    15 anzsrc-for:1107
    16 schema:author N3b0e410fd6464c3a911386a172359340
    17 schema:citation sg:pub.10.1038/244042a0
    18 sg:pub.10.1038/256495a0
    19 sg:pub.10.1038/266550a0
    20 https://doi.org/10.1002/eji.1830080802
    21 https://doi.org/10.1002/ijc.2910100316
    22 https://doi.org/10.1021/bi00777a002
    23 https://doi.org/10.1042/bj1160249
    24 https://doi.org/10.1042/bj1280427
    25 https://doi.org/10.1073/pnas.63.1.78
    26 https://doi.org/10.1073/pnas.71.9.3440
    27 https://doi.org/10.1111/j.1432-1033.1975.tb02478.x
    28 https://doi.org/10.1111/j.1600-065x.1977.tb00382.x
    29 schema:datePublished 1979-01
    30 schema:datePublishedReg 1979-01-01
    31 schema:description MONOCLONAL antibodies can be produced by cultures of permanent cell lines derived by fusion of suitable myelomas with spleen cells from immunised animals1. So far, mainly two mouse myelomas, X63-Ag8 and NSI/1-Ag4.1, have been used for this purpose1,2. When cells from immunised mice are used in the fusion, the mouse × mouse hybrid myelomas can be grown as tumours in appropriate mouse strains. We describe here the preparation and use of a new clone of a rat myeloma, which is suitable for the derivation of rat × rat hybrid myelomas producing specific rat antibodies. The spent medium of hybrid myeloma cultures usually contains 1–20 μg ml−1 antibody. The serum and ascites of the tumour-bearing mice, with few exceptions, yield 1–20 mg ml−1 of antibody, which is 1,000 times more concentrated and very convenient for larger preparations.
    32 schema:genre research_article
    33 schema:inLanguage en
    34 schema:isAccessibleForFree false
    35 schema:isPartOf N96df205a1bf741d2a2d687a44ac33e70
    36 Nfe995e43a4ab42e197e5835e09e2070c
    37 sg:journal.1018957
    38 schema:name Rat × rat hybrid myelomas and a monoclonal anti-Fd portion of mouse IgG
    39 schema:pagination 131
    40 schema:productId N017c231fd6174155a55e254218c9b5c3
    41 N706d009d802f4fbfa74d19941173b789
    42 N719f9608ecc04aca8b0d4fa7fc0f2dcb
    43 Nef34ae54d6a54c6e8775830c2060c129
    44 Nf696d4e734b54f28bb3677290c140ec8
    45 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039142189
    46 https://doi.org/10.1038/277131a0
    47 schema:sdDatePublished 2019-04-10T15:38
    48 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    49 schema:sdPublisher Ne14cb5a4de9d4a8db4404939081dfcc3
    50 schema:url https://www.nature.com/articles/277131a0
    51 sgo:license sg:explorer/license/
    52 sgo:sdDataset articles
    53 rdf:type schema:ScholarlyArticle
    54 N00b895534e3b412d97fbdc7dbbeb13a2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    55 schema:name Cell Line
    56 rdf:type schema:DefinedTerm
    57 N017c231fd6174155a55e254218c9b5c3 schema:name pubmed_id
    58 schema:value 310519
    59 rdf:type schema:PropertyValue
    60 N2b2d20c519314511909fb66fb8646de5 rdf:first N66b07ce09fb04e13b344af5b775796e0
    61 rdf:rest rdf:nil
    62 N30181fc9028743d38f96929f32a59e7b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    63 schema:name Plasmacytoma
    64 rdf:type schema:DefinedTerm
    65 N3118181ff9104491b3f311320bbe230e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    66 schema:name Clone Cells
    67 rdf:type schema:DefinedTerm
    68 N3b0e410fd6464c3a911386a172359340 rdf:first sg:person.01305136127.21
    69 rdf:rest Nb682e0a8cb07476d9e538a67beaf70bc
    70 N3dad8b9f849f4ee0b3de04354ad2e533 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    71 schema:name Rats
    72 rdf:type schema:DefinedTerm
    73 N4d6f4a6e14b54d9093ee02e831dbae40 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    74 schema:name Hybrid Cells
    75 rdf:type schema:DefinedTerm
    76 N66b07ce09fb04e13b344af5b775796e0 schema:familyName GALFRÈ
    77 schema:givenName G.
    78 rdf:type schema:Person
    79 N6c1a61993b204480b3f5ed2707e29989 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    80 schema:name Neoplasms, Experimental
    81 rdf:type schema:DefinedTerm
    82 N706d009d802f4fbfa74d19941173b789 schema:name nlm_unique_id
    83 schema:value 0410462
    84 rdf:type schema:PropertyValue
    85 N719f9608ecc04aca8b0d4fa7fc0f2dcb schema:name doi
    86 schema:value 10.1038/277131a0
    87 rdf:type schema:PropertyValue
    88 N7b5147d79f254c039d9c429ff8feab5f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    89 schema:name Antibody Specificity
    90 rdf:type schema:DefinedTerm
    91 N896656efa8f34d6597e10521aaa7d5fc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    92 schema:name Myeloma Proteins
    93 rdf:type schema:DefinedTerm
    94 N915452b8c7ac414eacbe25adecc2e9a1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    95 schema:name Immunoglobulin Fragments
    96 rdf:type schema:DefinedTerm
    97 N96df205a1bf741d2a2d687a44ac33e70 schema:issueNumber 5692
    98 rdf:type schema:PublicationIssue
    99 Na5c4864df17249538080e05d275338c6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    100 schema:name Species Specificity
    101 rdf:type schema:DefinedTerm
    102 Nb16754d4764142aa970734c9bb9387bb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    103 schema:name Immunoglobulin G
    104 rdf:type schema:DefinedTerm
    105 Nb682e0a8cb07476d9e538a67beaf70bc rdf:first sg:person.0104563066.64
    106 rdf:rest N2b2d20c519314511909fb66fb8646de5
    107 Nc51cc365c1094967bf06b6f055c6ab16 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    108 schema:name Animals
    109 rdf:type schema:DefinedTerm
    110 Nd9a53f33818c49168fd18a1341f0ab54 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    111 schema:name Antibodies, Anti-Idiotypic
    112 rdf:type schema:DefinedTerm
    113 Ne14cb5a4de9d4a8db4404939081dfcc3 schema:name Springer Nature - SN SciGraph project
    114 rdf:type schema:Organization
    115 Nef34ae54d6a54c6e8775830c2060c129 schema:name readcube_id
    116 schema:value ba73d542b2591b6bcfff0b8484c801331fa48fe244c78ae58965035ef4975b7c
    117 rdf:type schema:PropertyValue
    118 Nf696d4e734b54f28bb3677290c140ec8 schema:name dimensions_id
    119 schema:value pub.1039142189
    120 rdf:type schema:PropertyValue
    121 Nfe995e43a4ab42e197e5835e09e2070c schema:volumeNumber 277
    122 rdf:type schema:PublicationVolume
    123 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    124 schema:name Medical and Health Sciences
    125 rdf:type schema:DefinedTerm
    126 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
    127 schema:name Immunology
    128 rdf:type schema:DefinedTerm
    129 sg:journal.1018957 schema:issn 0090-0028
    130 1476-4687
    131 schema:name Nature
    132 rdf:type schema:Periodical
    133 sg:person.0104563066.64 schema:familyName MILSTEIN
    134 schema:givenName C.
    135 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0104563066.64
    136 rdf:type schema:Person
    137 sg:person.01305136127.21 schema:familyName WRIGHT
    138 schema:givenName B.
    139 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01305136127.21
    140 rdf:type schema:Person
    141 sg:pub.10.1038/244042a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004074762
    142 https://doi.org/10.1038/244042a0
    143 rdf:type schema:CreativeWork
    144 sg:pub.10.1038/256495a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001387921
    145 https://doi.org/10.1038/256495a0
    146 rdf:type schema:CreativeWork
    147 sg:pub.10.1038/266550a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023163215
    148 https://doi.org/10.1038/266550a0
    149 rdf:type schema:CreativeWork
    150 https://doi.org/10.1002/eji.1830080802 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026826519
    151 rdf:type schema:CreativeWork
    152 https://doi.org/10.1002/ijc.2910100316 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039713270
    153 rdf:type schema:CreativeWork
    154 https://doi.org/10.1021/bi00777a002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1055188173
    155 rdf:type schema:CreativeWork
    156 https://doi.org/10.1042/bj1160249 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041484764
    157 rdf:type schema:CreativeWork
    158 https://doi.org/10.1042/bj1280427 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050611617
    159 rdf:type schema:CreativeWork
    160 https://doi.org/10.1073/pnas.63.1.78 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047016203
    161 rdf:type schema:CreativeWork
    162 https://doi.org/10.1073/pnas.71.9.3440 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014786242
    163 rdf:type schema:CreativeWork
    164 https://doi.org/10.1111/j.1432-1033.1975.tb02478.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1037964148
    165 rdf:type schema:CreativeWork
    166 https://doi.org/10.1111/j.1600-065x.1977.tb00382.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1027700902
    167 rdf:type schema:CreativeWork
     




    Preview window. Press ESC to close (or click here)


    ...